Angiocrine Bioscience
Angiocrine Bioscience is a biotech company focused on applying vascular biology to therapeutic applications. They develop and market products based on endothelial cells that support cell-based therapies, stem cell transplants, and regenerative medicine. Their mission is to positively impact patients' lives through innovative vascular and stem cell technologies.
Industries
biotechnology
health-care
health-diagnostics
therapeutics
Nr. of Employees
small (1-50)
Angiocrine Bioscience
New York, New York, United States, North America
Patents
Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
US-10947500-B2
View Details
Neural cells expressing adenovirus E4ORF1, and methods of making and using the same
US-10947500-B2
View DetailsProducts
Research-grade engineered endothelial cell platform (research-use only)
Genetically modified endothelial cell products designed to provide a vascular niche in vitro for expansion and support of stem cells and for use in research assays.
Research-grade engineered endothelial cell platform (research-use only)
Genetically modified endothelial cell products designed to provide a vascular niche in vitro for expansion and support of stem cells and for use in research assays.
Services
Licensing of vascular niche and stem cell reprogramming technologies to third parties.
Licensing of vascular niche and stem cell reprogramming technologies to third parties.
Expertise Areas
- Engineered endothelial platforms and vascular niche engineering
- Hematopoietic stem cell expansion and reprogramming
- Transcription-factor-mediated lineage reprogramming
- Signaling pathway modulation for cell fate and regeneration
Key Technologies
- Engineered endothelial cell platforms
- Transcription-factor-mediated reprogramming
- Vascular niche co-culture systems
- Serum-free endothelial culture enabled by targeted signaling activation